Bulls N' Bears (Commercial Content)

A banana thrown at Eddie Betts… The IOC apologies to the 10 athletes who were thrown in a Brazilian jail… The Aussie team’s “hit & misses”….

Sipa Resources have more than doubled the anticipated cap on their share purchase plan to $4.2 million after a flood of applications from bullish shareholders. The rush coincides with the start of a maiden drilling program at the Paterson North project, which is on strike from the ground generating so much good news for Antipa and its JV partner Rio Tinto.

BHP’s $8 Billion loss is casting doubt on its CEO getting paid well over $10M in cash and incentives…

Well-known Perth broker Euroz is predicting a 50% increase in the lithium resource at Neometals’ Mt Marion project near Coolgardie. The prediction, which is based on recent spectacular drill results at the project, would take the Mt Marion resource from 60m tonnes to 90m tonnes, placing it right up there with some of the largest hard rock deposits in the world. 

BHP had its worst half in over 50 years as the miner posted a “huge” loss ($6.4 billion) on write-downs in Brazil.

There seems to be no end in sight to the run on Blackham Resources’ share price that started in September last year at 15c and touched $1.15 today on the back of more, classic Blackham, super high grade drill hits at the Matilda Gold project – the project that just keeps on giving.  Results out today include 6.0m @ 26.4 g/t gold, including 1.8 metres at a whopping 83.3 g/t, and 15.6 metres at 7.51 g/t.

Another very busy day ahead for us with the RBA minutes and BHP, BKN, CGF and WBC to name some of the big names set to report…

Blackham Resources shares have surged again with news that the first gold pour at the 100,000+ ounce-a-year Matilda gold project in Wiluna W.A is just weeks away. The first gold bar at Matilda will mark the first major milestone in Blackham’s remarkable revival of the largely mothballed project in Wiluna. Shares in Blackham surged 4.5c to $1.02 on the news. 

Legend Mining have wasted no time getting back into the field for a series of moving loop electromagnetic survey’s at their Rockford project in the Fraser Range, home to the giant Nova-Bollinger nickel deposit. They recently completed a round of exploratory drilling at Rockford which the company says has greatly assisted it to better understand the geology at the Fraser Range.

The Olympics has certainly been entertaining and yes, the Hawks are still on top of the ladder (just).

Cashed up Neometals is returning $11.3 million to shareholders even before production begins at Mt Marion in the December quarter. The savvy junior held $74 million in cash at 30 June and is distributing to shareholders some of the rewards of its great deal making. This is the second time in a year that Neometals have announced a dividend before production has even started. 

It surely has been another busy weak, as the AUS reporting season has gathered steam….

Medical cannabis company MGC Pharmaceuticals has agreed to sell two African-based exploration permits and related data for $500,000 in cash. The legacy mining assets no longer form part of the company's core business focus as it finalises the transition away from mineral exploration as Erin Resources and into a leading edge medical marijuana company. 

New drill results suggest that Neometal’s world-class Mt Marion Lithium Project near Coolgardie is set for even further growth in its total resource and that's in addition to the recently announced 160% increase. Neometals, who today announced the conclusion of their 147 hole drilling program at Mt Marion currently hold a 13.8% free carried stake in the project.

ATM business Stargroup looks set to give its balance sheet a boost by again revaluing its stake in South Korean ATM manufacturer NeoICP after the ATM manufacturer and Stargroup supplier posted a bumper result for the 2016 financial year. Stargroup holds an 11.28% strategic stake in private Korean company NeoICP and will shortly receive a $60 000 dividend cheque.

Just like the stock market, the Americans are “hurting” us once again…

ASX listed biotech company PharmAust today announced that a leading veterinary specialist would conduct more canine trials with its promising anti-cancer drug "MP"L. NSW-based dog cancer specialist, Dr Angela Frimberger, will evaluate MPL either as a monotherapy or in conjunction with chemotherapy in dogs that have not responded to standard cancer treatments.

Financial payments upstart Stargroup, today reported record monthly ATM transactions from its Australia wide ATM machine network for July and predicted its 11thconsecutive quarter of revenue growth. Revenues from the ATM business in July were well in excess of $500,000, more than the company’s entire revenue for FY15 with an annualized rate of $6.7 million.

The highly anticipated drill testing of Hammer Metals' promising Overlander prospect near Mt Isa in Queensland will kick off next month with drill hole positions now determined. Hammer metals, with giant JV partner Newmont, will target a repetition of the famed 220m tonne Ernest Henry iron oxide copper-gold deposit east of Mt Isa. 

An eventful night for the Australian Bureau of Statistics (ABS) with the website down, following the Census due to “hacking” concerns?

China has had a big night in the medal tally, however, in about 20 minutes, our Aussie girls are going for Gold in the rugby 7s vs. New Zealand….

Legend Mining today partly realized a profit of $3.46m after selling Independence Gold shares it bought on market back in 2012. The sale provided a healthy kick for the Fraser Range explorer’s share price and a boost to its cash reserves to $8.5 million. In total, Legend has received $5,332,162 worth of cash and script for its $1.87m investment in the then Sirius Resources.

The AUS reporting season gathers steam with a number of the big names reporting….

ASX listed cancer drug hopeful Pharmaust have secured additional IP rights to their highly promising anti-cancer drug Monepantel by partially trading off rights to another project under their control. Under the new deal, Pharmaust will receive the remainder of the IP rights to Monepantel that were never transferred to them by the University of NSW.

Analytica have patented their unique medical device in one of the worlds most populous markets. The People’s Republic of China recently granted Analytica’s patent application for the company’s “Peri-Coach" pelvic floor force sensing device. The Peri-Coach can eliminate urinary incontinence, a condition afflicting nearly 230m Chinese women according to the company. 

So the Bank of England cut growth forecasts by the most ever and announced a large stimulus, as policy makers unveiled a stimulus package aimed at containing the fallout from the U.K.’s secession vote.

Well known mining focused private equity firm Resource Capital Funds has taken a plunge at ASX junior Hammer Metals with its latest $2b mining fund. RCF has taken a $1.75m placement in Hammer Metals at 7c a share representing the lion’s share of the company’s latest $2.25m capital raise. The funds will be spent on Hammer's100% owned Mt Isa copper gold project. 

The last two days on the ASX have been tough, losing ~ 120 points, however, we should have a strong start today, with the SPI + 28

So… Glenn Stevens listened to us and cut interest rates to a record low of 1.5%.

Today, our friends at the RBA meet to decide whether to cut official interest rates…. Over 70% of economists surveyed suggest that they will cut interest rates.We tend to agree… With inflation sitting near record lows and consumer & business confidence not improving, the RBA will cut interest rates today by 25bp

Good Morning, “A pinch and a punch”… yes, it’s the first day of the month… and boy, do we have a busy month ahead. So July was a very good month for equities…Brexit… what Brexit? A potential “hung-parliament”… who cares…. Japanese stimulus that failed to stimulate growth and a Chinese market rippled by debt….

Medical device company Analytica has attracted further interest from Virgin Islands based investment fund INOV8 who will stump up $500k at .007c a share to take their second placement in the company. INOV8 have tripled their $500k plunge at Analytica back in March when they successfully picked the bottom of the company’s share price graph at just .00255c a share.